S&P 500 Futures Fall in Premarket Trading; Roivant Sciences, DoubleVerify Lead barrons.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from barrons.com Daily Mail and Mail on Sunday newspapers.
Global healthcare major Johnson & Johnson on Tuesday said it has sought an approval from the India s drug regulator to conduct a bridging clinical trial of its single-dose Covid-19 vaccine in the country. The US Food and Drug Administration (USFDA) had in February approved Johnson & Johnson s Covid-19 vaccine that works with just one dose for emergency use. Johnson & Johnson is partnering with health authorities and the world s best scientists to provide the safety and efficacy data necessary to support worldwide emergency use of the Janssen Covid-19 vaccine candidate, the company said ina statement. This comes close on the heels of the central government last week deciding to fast-track emergency approvals for all foreign produced coronavirus jabs that have been given a similar nod by the World Health Organization or regulators in the United States, Europe, Britain or Japan.